Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:


    Update your notification preferences


    Access government services


    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Viscosupplementation (FOI)

Viscosupplementation (FOI)

Produced by the Freedom of Information office
Authored by States of Jersey and published on 04 October 2018.


Under the Freedom of Information Act, please could you answer the following questions:


Does Jersey General Hospital use / perform Viscosupplementation injections?


If so, how much did Jersey General Hospital spend on Viscosupplementation between the period of 1 January 2017 and 31 December 2017?


If Jersey General Hospital used Viscosupplementation between the period 1 January 2017 and 31 December 2017, which brand(s) did you use? To make your research easier, I have listed all commonly used Viscosupplements that you can cross reference:

  • Arthrum H

  • Orthovisc

  • Crespine Gel

  • Durolane

  • Euflexxa

  • Fermathron

  • Ostenil

  • Ostenil Plus

  • RenehaVis

  • Suplasyn

  • Synocrom

  • Synocrom Mini

  • Synolis

  • Monovisc

  • Synopsis

  • Synvisc (Hylan GF-20)

  • Synvisc One (Hylan GF-20)


How many units of each brand of Viscosupplement did you use?





This request has been refused and Article 33 (Commercial Interests) of the Freedom of Information (Jersey) Law 2011 has been applied.


In 2017 the Hospital Pharmacy dispensed Durolane and Synvisc.


Durolane – 54 units

Synvisc – 7 units

It should be noted that other products may have been used, however, they were not issued by the Hospital Pharmacy.

Article applied

Article 33 Commercial interests

Information is qualified exempt information if –

(a) it constitutes a trade secret; or

(b) its disclosure would, or would be likely to, prejudice the commercial interests of a person (including the scheduled public authority holding the information).

The department can confirm that it holds this information. However, the cost is commercially sensitive to the Health and Social Services Department and its suppliers.

Having considered the public interest, the department has decided to withhold the cost of Durolane and Synvisc for 2017 as it is considered that releasing this information would be likely to prejudice the department’s ability to obtain them at the best price.

Back to top
rating button